Cannabis franchise firm Releaf Group has secured agreements to import South African medicinal cannabis into Australia.
An agreement with the South African Health Products Regulatory Authority and the International Narcotics Control Board will establish a supply chain between South Africa and Australia, while wholly owned subsidiary Releaf Dispensaries has signed a supply deal with GMP-licensed South African producer, FarmaGrowers.
Releaf Group CEO Gary Mackenzie said: “We are excited about the opportunity with FarmaGrowers to establish a long-term importation supply chain from a GMP-certified facility in South Africa that will introduce a significant product mix of South African cultivars to the Australia and New Zealand marketplace.”
FarmaGrowers CEO Mario Marais said the company’s main objective since its inception was to compete internationally, specifically with high THC products.
He added: “Today, we have turned this vision into a reality by building a fully operational GMP-approved medicinal cannabis facility and signing an international off-take agreement with Releaf Group. We look forward to this new cultivation and medical expertise partnership as it aligns with our slogan ‘Growing Health’.”
Releaf group is focused on expanding its range of dried flower to provide therapeutic options and to support the roll-out of its clinic and dispensary (pharmacy) franchise model.
